Radioisotope developer MDS Nordion of Kanata, Ontario, announced the sale of its external beam therapy and self-contained irradiator product lines in a move to focus the firm's attention on molecular medicine initiatives.
Radiotherapy and oncology products firm Best Medical International of Springfield, VA, will acquire the two product lines, which have combined annualized revenues of $32 million (U.S.), MDS Nordion said. The transaction is expected to close over the next three months.
Terms of the deals were not disclosed.
Related Reading
MDS Nordion signs cobalt-60 supply pact, October 19, 2007
MDS Nordion to help create molecular imaging center, June 5, 2007
Molecular imaging, nuclear medicine share spotlight at SNM 2007, June 4, 2007
MDS Nordion reports glitch in iodine-131 supply, April 20, 2007
MDS Nordion to partner with Avid Radiopharmaceuticals, April 4, 2007
Copyright © 2007 AuntMinnie.com
